Drug Type Small molecule drug |
Synonyms BR 3003, BR-3003, BR3003 + [1] |
Mechanism AMPK agonists(AMP activated protein kinase agonists), P-gp inhibitors(P-glycoprotein 1 inhibitors), PPARγ agonists(Peroxisome proliferator-activated receptor γ agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H21ClN2O3S |
InChIKeyGHUUBYQTCDQWRA-UHFFFAOYSA-N |
CAS Registry112529-15-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 3 | KR | 28 May 2021 | |
Diabetes Mellitus | Phase 3 | KR | - |